Logo

American Heart Association

  24
  0


Final ID: P3069

Effect of cocoa extract supplementation on incident hypertension in the COSMOS trial

Abstract Body: Backgrounds: Cocoa flavanols have potential blood pressure (BP)-lowering effects in shorter-term, smaller-scale randomized clinical trials (RCTs), but its effect on incident hypertension has not been examined in a large-scale RCT. The COcoa Supplement and Multivitamin Outcomes Study (COSMOS) evaluated whether longer-term cocoa extract supplementation had an effect on incident hypertension in older adults.
Methods: COSMOS is a 2x2 factorial, double-blind, placebo-controlled RCT testing cocoa extract (including 500 mg/day cocoa flavanols, with 80 mg/day (-)-epicatechin) and a multivitamin among 21,442 women aged ≥65y and men aged ≥60y. In 8,905 COSMOS participants free from baseline self-reported hypertension, we investigated the effect of cocoa extract on incident hypertension using Cox proportional hazards models. Incident hypertension was defined as self-reported first-time physician diagnosis, initiation of anti-hypertensive medications, or self-reported elevated systolic BP (SBP) ≥ 140 mmHg or diastolic BP (DBP) ≥ 90 mmHg.
Results: Mean age at baseline was 71.1 years (SD: 6.2) and 58.8% of the participants were women. 48.6% had baseline SBP < 120 mmHg, corresponding to the normal range. Baseline characteristics were balanced between the cocoa extract and placebo groups. Over a median follow-up of 3.4 years, in intention-to-treat analyses cocoa extract supplementation had no significant effect on incident hypertension, with the incidence rates (IRs) of 71.2 and 73.8 per 1000 person-years in cocoa and placebo groups, respectively (hazard ratio [HR]: 0.96 [95% confidence interval: 0.88, 1.05]). A significant interaction was observed between treatment assignment and baseline SBP (p=0.002). Cocoa extract supplementation reduced the incidence of hypertension among participants with baseline SBP < 120 mmHg (IR: 38.2 vs. 50.3 per 1000 person-years; HR: 0.76 [0.64, 0.90]), but not among those with SBP of 120-139 mmHg (IR: 101.4 vs. 96.8 per 1000 person-years; HR: 1.05 [0.93, 1.18]; Figure). Consistent results were obtained in sensitivity analyses using different definitions of hypertension: physician diagnosis, initiation of anti-hypertensive medications, or elevated BP alone. Per-protocol analysis using inverse probability weighting to account for non-adherence also supported the effect in SBP < 120 mmHg.
Conclusion: In older adults, years-long supplementation of cocoa extract may reduce the risk of incident hypertension among those with normal BP levels.
  • Hamaya, Rikuta  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Li, Sidong  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Lau, Jessica  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Rist, Pamela  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Manson, Joann  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Sesso, Howard  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Author Disclosures:
    Rikuta Hamaya: DO have relevant financial relationships ; Executive Role:Everyone Cohort Inc.:Active (exists now) | Sidong Li: No Answer | Jessica Lau: No Answer | Pamela Rist: DO NOT have relevant financial relationships | JoAnn Manson: No Answer | Howard Sesso: DO NOT have relevant financial relationships
Meeting Info:
Session Info:

PS03.06 Hypertension 2

Saturday, 03/08/2025 , 05:00PM - 07:00PM

Poster Session

More abstracts on this topic:
A Meta-analysis of Folic Acid Supplementation Efficacy in Cardiovascular Diseases Prevention.

Calderon Martinez Ernesto, Camacho Davila Karen Fabiola, Pinto-colmenarez Rafael, Arruarana Victor, Arvelaez Pascucci Joanne, Castillo Jaqueline Livier, Alonso Ramirez Angie Carolina, Ghattas Patricia, Giron De Marza Maria, Sosaya Zuñiga Briggitte Solange, Martinez Lilan Jonathan David, Paredes Romero Enrique

A major effect of aprocitentan on albuminuria in patients with resistant hypertension

Schlaich Markus, Bakris George, Flack John, Gimona Alberto, Narkiewicz Krzysztof, Sassi-sayadi Mouna, Wang Jiguang, Weber Michael

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available